Profile data is unavailable for this security.
About the company
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
- Revenue in USD (TTM)40.19m
- Net income in USD-57.74m
- Incorporated2006
- Employees216.00
- LocationSonendo Inc26061 Merit Circle, Suite 102LAGUNA HILLS 92653United StatesUSA
- Phone+1 (949) 766-3636
- Fax+1 (302) 636-5454
- Websitehttps://sonendo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Nuwellis Inc | 8.90m | -19.93m | 4.94m | 59.00 | -- | 2.10 | -- | 0.5556 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.07m | 7.00 | -- | 4.60 | -- | 1.78 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 5.21m | 15.00 | -- | -- | -- | 2.29 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 5.28m | 157.00 | -- | -- | -- | 0.1074 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Vapotherm Inc | 70.07m | -54.94m | 5.33m | 182.00 | -- | -- | -- | 0.076 | -8.62 | -8.62 | 11.00 | -11.02 | 0.8122 | 1.46 | 7.53 | 385,011.00 | -63.68 | -49.73 | -587.27 | -62.54 | 45.28 | 43.56 | -78.40 | -78.99 | 0.1259 | -1.27 | 2.59 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
| Guided Therapeutics Inc | 98.00k | -3.76m | 5.56m | 4.00 | -- | -- | -- | 56.75 | -0.074 | -0.074 | 0.0019 | -0.0703 | 0.0389 | 0.1051 | 15.08 | 24,500.00 | -138.59 | -136.13 | -- | -- | 36.73 | 29.39 | -3,560.20 | -3,666.67 | 0.1582 | -12.94 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.857 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Avinger Inc | 7.65m | -18.32m | 6.33m | 68.00 | -- | -- | -- | 0.8275 | -26.38 | -26.38 | 9.74 | -4.85 | 0.4031 | 1.10 | 7.39 | 112,529.40 | -96.51 | -70.93 | -5,095.97 | -131.57 | 26.18 | 30.87 | -239.41 | -208.91 | 0.3557 | -9.68 | 1.77 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Sigyn Therapeutics Inc | 0.00 | -4.15m | 6.43m | 5.00 | -- | -- | -- | -- | -3.82 | -3.82 | 0.00 | -2.65 | 0.00 | -- | -- | 0.00 | -1,266.54 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0189 | -1.20 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Predictive Oncology Inc | 1.78m | -13.98m | 6.89m | 34.00 | -- | 0.8252 | -- | 3.87 | -3.48 | -3.48 | 0.4434 | 2.04 | 0.0887 | 1.37 | 5.35 | 52,355.88 | -69.66 | -91.80 | -86.54 | -126.29 | 64.34 | 64.64 | -785.57 | -1,419.99 | 2.43 | -- | 0.0179 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Sonendo Inc | 40.19m | -57.74m | 7.05m | 216.00 | -- | 0.2872 | -- | 0.1753 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Vivos Therapeutics Inc | 13.80m | -13.58m | 7.29m | 114.00 | -- | 10.08 | -- | 0.5285 | -11.08 | -11.08 | 11.49 | 0.2241 | 1.13 | -- | 41.88 | 121,061.40 | -111.11 | -89.72 | -262.52 | -149.70 | 59.93 | 70.20 | -98.42 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 7.42m | 12.00 | -- | 0.8333 | -- | 398.66 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| Neurometrix Inc | 5.90m | -6.53m | 8.14m | 26.00 | -- | 0.3112 | -- | 1.38 | -6.29 | -6.29 | 5.67 | 13.18 | 0.2561 | 1.23 | 10.13 | 226,977.70 | -28.33 | -23.24 | -29.85 | -27.26 | 66.89 | 59.17 | -110.64 | -48.88 | 15.55 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Data as of May 16 2024. Currency figures normalised to Sonendo Inc's reporting currency: US Dollar USD
29.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 31 Dec 2023 | 5.45m | 8.16% |
| Pura Vida Investments LLCas of 31 Dec 2023 | 5.42m | 8.12% |
| Masters Capital Management LLCas of 31 Dec 2023 | 5.00m | 7.49% |
| Driehaus Capital Management LLCas of 31 Jan 2024 | 2.63m | 3.94% |
| Wedbush Securities, Inc. (Investment Management)as of 31 Dec 2023 | 693.62k | 1.04% |
| Federated Equity Management Company of Pennsylvaniaas of 31 Dec 2023 | 120.00k | 0.18% |
| Granite Investment Partners LLCas of 31 Dec 2023 | 57.00k | 0.09% |
| XTX Markets LLCas of 31 Dec 2023 | 27.77k | 0.04% |
| Blue Water Life Science Advisors LPas of 31 Dec 2023 | 0.00 | 0.00% |
| RBC Dominion Securities, Inc.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
